Primary endocrine treatment, a new approach for patients with breast tumours

At Onkologikoa we are leaders in the use of an innovative therapeutic approach whereby the treatment of patients with breast cancer begins, before surgery, with 6 months of hormone treatment.

The key to an excellent treatment lies in its personalisation, in its adaptation to each patient’s needs, and in keeping its side effects to a minimum. Thus, at Onkologikoa we have introduced to our guide for treating “luminal” breast cancers (those with a positive hormone receptor expression) an approach involving hormone treatment (one pill every day, generally very well tolerated) for six months, with strict monitoring. This treatment is followed by surgical ablation of the tumour; if while doing so we find that there is adequate tumour response, the patient can potentially avoid chemotherapy in the majority of cases.

You may also be interested in


Thanks to collaboration with the IVF Donostia (Basque Fertility Institute), we work to prevent hereditary cancer. Using the most advanced assisted reproduction techniques, such as…

Continue reading

Having a mastectomy is an effective solution. However, it causes disfigurement and can be traumatic for patients. To palliate and solve the problems inherent to…

Continue reading

We'll call you in 24 hours

Fill in your details and tell us why you're calling, so that we can deal with you in the most personal and efficient way possible.

You can call us too if you'd rather.